HAWK Biosystems

HAWK Biosystems

Unveiling protein function in patient samples to discovery breakthrough biomarkers.

Founded 2015 Spain

Spain 22 employees Grant Total: $951.64K Biotechnology, Health Care

HAWK Biosystems is a biotechnology startup based in Spain, founded in 2016 by Spanish and British scientists from the Francis Crick Institute in London. Formerly known as FASTBASE Solutions, the company aims to unveil protein function in patient samples to discover breakthrough biomarkers. Their flagship technology, QF-Pro®, allows for the discovery and quantification of novel biomarkers within any disease state with high precision. HAWK Biosystems addresses the increasing demand in biotechnology and healthcare industries by offering the QF-Pro® service, which is utilized to discover and quantify biomarkers in FFPE tissue and cell samples. Additionally, the company provides a custom assay creation service to cater to the specific needs of their clients. The company's innovative approach has attracted the attention of The European Innovation Council, which became their most recent investor with a grant investment at 28 February 2024. This investment signifies a recognition of the potential of HAWK Biosystems' technology to revolutionize the field of biomarker discovery and patient stratification for personalized treatment in various disease states.

Funding Stage	Amount	Investors	Lead Investors	Date
Grant	Undisclosed	1	EIC Accelerator	28 Feb 2024
Equity Crowdfunding	€230.21K	1	Crowdcube	24 Mar 2022
Seed Round	Undisclosed	1	Seed Capital Bizkaia	13 Jan 2021
Equity Crowdfunding	€650.00K	-		06 Aug 2020
Grant	€71.43K	1	EASME - EU Executive Agency for SMEs	01 Feb 2018

Funding Stage

Amount

Investors

Lead Investors

Date

Grant

Undisclosed

EIC Accelerator

28 Feb 2024

Equity Crowdfunding

€230.21K

Crowdcube

24 Mar 2022

Seed Round

Undisclosed

Seed Capital Bizkaia

13 Jan 2021

Equity Crowdfunding

€650.00K

06 Aug 2020

Grant

€71.43K

EASME - EU Executive Agency for SMEs

01 Feb 2018

FAQ About HAWK Biosystems

Unveiling protein function in patient samples to discovery breakthrough biomarkers.

HAWK Biosystems was founded in 2015.

HAWK Biosystems is headquartered in Spain.

HAWK Biosystems operates in Biotechnology and Health Care. Its work centres on biomarker discovery, protein function, patient samples and immunotherapy.

HAWK Biosystems has approximately 22 employees.

HAWK Biosystems has completed 5 funding rounds, raising a total of $951.64K. The latest funding stage is Grant.

Top alternatives and competitors to HAWK Biosystems include OncoDNA, Empire Genomics, Avenzo Therapeutics, Capio Biosciences, Ophiomics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

HAWK Biosystems and OncoDNA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About HAWK Biosystems

Funding Rounds & Investors (5)

HAWK Biosystems Alternatives & Competitors

FAQ About HAWK Biosystems